NOCDURNA: payments to doctors
Payments that named NOCDURNA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.4M
- Providers
- 12,388
- Transactions
- 39,910
- Average per transaction
- $34
The per-transaction average — $34 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 12,388 providers the average total is $109, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Antares Pharma, Inc. | $927,249 | 68.6% |
| Ferring Pharmaceuticals Inc. | $401,335 | 29.7% |
| Ferring Pharmaceuticals AS | $23,012 | 1.7% |
| Supernus Pharmaceuticals, Inc. | $456 | 0.0% |
| Ferring International Pharmascience Center US | $439 | 0.0% |
| Ferring International Center SA | $69 | 0.0% |